India, Oct. 19 -- Shares of Centogene N.V. (CNTG) are rising more than 11% Monday morning after the company said it has received Emergency Use Authorization (EUA) from the FDA for 'CentoSure', the company's latest SARS-CoV-2 RT-PCR test.
The EUA allows to use this test to use for individuals with no symptoms of Covid-19 or other reasons to suspect the disease.
Centogene stock is currently trading at $12.11. It has been trading in the range of $7.80- $28.71 in the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....